Theseus Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Theseus Pharmaceuticals, Inc.

Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. Its lead product candidate is THE-630, a pan-KIT inhibitor for the treatm…

Biotechnology
US, Cambridge [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

Theseus Pharmaceuticals, Inc. has no acquisition track records yet.

M&A Deals · History

Theseus Pharmaceuticals, Inc. has no acquisition track records yet.

End of THRX's Analysis
CIK: 1745020 CUSIP: 88369M101 ISIN: US88369M1018 LEI: - UEI: -
Secondary Listings
THRX has no secondary listings inside our databases.